Biotech News

Home Biotech News

No posts to display

- Advertisement -

APPLE

Durect Reports Favorable Data from NASH Study

California-based specialty drug manufacturer Durect Corporation (NASDAQ:DRRX) announced positive topline results from its phase 1B clinical study of DUR-928 for the treatment of nonalcoholic...

RECENT POSTS